AarogyaAI aims to diagnose drug-resistant tuberculosis (DR-TB) using Artificial Intelligence in a few hours. We enable quick and accurate diagnosis of DR-TB so that the patient can be rightly prescribed effective drug combinations for treatment, instantly.
As a young start-up in the space of healthcare technology, we have drawn on the experiences of our peers and relied on this growing community of entrepreneurs to navigate complexities in compliances, IP laws and taxes for startups in India. Through this community, we have also had the opportunity to share our vision, our story and where we want to go from here.
Total Funding: $699.6 K
Funding Stage: Seed
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2019
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at AarogyaAI
